Skip to content

Clinical trials

Observational Graft vs Host Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Observational Country / region: United States Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20053
20062
20072
20083
20091
20102
20113
20122
20133
20143
20152
20171
20181
20191
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting6
Terminated3
Active, not recruiting2
Enrolling by invitation2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ann & Robert H Lurie Children's Hospital of Chicago3
National Cancer Institute (NCI)3
National Heart, Lung, and Blood Institute (NHLBI)3
Vanderbilt-Ingram Cancer Center3
City of Hope Medical Center2
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
National Institute of Dental and Craniofacial Research (NIDCR)2
Vanderbilt University2
Boston Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease38
Bronchiolitis Obliterans Syndrome5
Autoimmune Diseases4
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Neoplasms3
Lymphoma3
Lymphoma, T-Cell, Cutaneous3
Multiple Myeloma3

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.